itraconazole has been researched along with Muscle Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damian, MS; Duncan, AJ; Hargreaves, IP; Heales, SJ; Land, JM | 1 |
| Bottorff, M; Worz, CR | 1 |
1 review(s) available for itraconazole and Muscle Disorders
| Article | Year |
|---|---|
The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins.
Topics: Aged; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Isoenzymes; Itraconazole; Lovastatin; Male; Middle Aged; Muscular Diseases; Pravastatin; Rhabdomyolysis; Simvastatin | 2001 |
1 other study(ies) available for itraconazole and Muscle Disorders
| Article | Year |
|---|---|
Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
Topics: Aged; Animals; Astrocytes; Cells, Cultured; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Electron Transport Complex IV; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Rats; Rhabdomyolysis; Simvastatin; Ubiquinone | 2009 |